117 related articles for article (PubMed ID: 3038642)
1. Altered action of glucagon on human liver in type 2 (non-insulin-dependent) diabetes mellitus.
Arner P; Einarsson K; Ewerth S; Livingston JN
Diabetologia; 1987 May; 30(5):323-6. PubMed ID: 3038642
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
3. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
Portha B; Chamras H; Broer Y; Picon L; Rosselin G
Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
[TBL] [Abstract][Full Text] [Related]
4. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
[TBL] [Abstract][Full Text] [Related]
5. N-ethylmaleimide uncouples the glucagon receptor from the regulatory component of adenylyl cyclase.
Lipson KE; Kolhatkar AA; Dorato A; Donner DB
Biochemistry; 1986 Sep; 25(19):5678-85. PubMed ID: 3022802
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
[TBL] [Abstract][Full Text] [Related]
7. Lowered responsiveness of the catalyst of adenylyl cyclase to stimulation by GS in heterologous desensitization: a role for adenosine 3',5'-monophosphate-dependent phosphorylation.
Premont RT; Jacobowitz O; Iyengar R
Endocrinology; 1992 Dec; 131(6):2774-84. PubMed ID: 1332848
[TBL] [Abstract][Full Text] [Related]
8. Determination of G-protein levels, ADP-ribosylation by cholera and pertussis toxins and the regulation of adenylyl cyclase activity in liver plasma membranes from lean and genetically diabetic (db/db) mice.
Palmer TM; Houslay MD
Biochim Biophys Acta; 1991 Oct; 1097(3):193-204. PubMed ID: 1932144
[TBL] [Abstract][Full Text] [Related]
9. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
Craven PA; Derubertis FR
Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane.
Lee CR; Hamm MW
J Nutr; 1989 Apr; 119(4):539-46. PubMed ID: 2539445
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of two glucagon antagonists: receptor binding, adenylate cyclase, and effects on blood plasma glucose levels.
Gysin B; Johnson DG; Trivedi D; Hruby VJ
J Med Chem; 1987 Aug; 30(8):1409-15. PubMed ID: 3039134
[TBL] [Abstract][Full Text] [Related]
12. Altered glucagon- and catecholamine hormone-sensitive adenylyl cyclase responsiveness in rat liver membranes induced by manipulation of dietary fatty acid intake.
Dax EM; Partilla JS; Piñeyro MA; Gregerman RI
Endocrinology; 1990 Nov; 127(5):2236-40. PubMed ID: 2226311
[TBL] [Abstract][Full Text] [Related]
13. The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.
Murphy GJ; Hruby VJ; Trivedi D; Wakelam MJ; Houslay MD
Biochem J; 1987 Apr; 243(1):39-46. PubMed ID: 3038085
[TBL] [Abstract][Full Text] [Related]
14. Glucagon stimulates adenylate cyclase through GR2 glucagon receptors: a process which can be attenuated by glucagon stimulating inositol phospholipid metabolism through GR1 glucagon receptors.
Houslay MD; Wakelam MJ; Murphy GJ; Gawler DJ; Pyne NJ
Biochem Soc Trans; 1987 Feb; 15(1):21-4. PubMed ID: 3030839
[No Abstract] [Full Text] [Related]
15. Forskolin regulation of liver membrane adenylyl cyclase.
Birnbaumer L; Stengel D; Desmier M; Hanoune J
Eur J Biochem; 1983 Oct; 136(1):107-12. PubMed ID: 6604628
[TBL] [Abstract][Full Text] [Related]
16. Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.
Allgayer H; Bachmann W; Hepp KD
Diabetologia; 1982 Jun; 22(6):464-7. PubMed ID: 6286396
[TBL] [Abstract][Full Text] [Related]
17. Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone.
Christoffersen T; Refsnes M; Brønstad GO; Ostby E; Huse J; Haffner F; Sand TE; Hunt NH; Sonne O
Eur J Biochem; 1984 Jan; 138(2):217-26. PubMed ID: 6321168
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced diabetes and hormone sensitivity of adenylate cyclase in rat myocardial sarcolemma, aorta and liver.
Srivastava AK; Anand-Srivastava MB
Biochem Pharmacol; 1985 Jun; 34(11):2013-7. PubMed ID: 4039939
[TBL] [Abstract][Full Text] [Related]
19. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin.
Illiano G; Cuatrecasas P
Science; 1972 Feb; 175(4024):906-8. PubMed ID: 4332823
[TBL] [Abstract][Full Text] [Related]
20. Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist.
Unson CG; Gurzenda EM; Merrifield RB
Peptides; 1989; 10(6):1171-7. PubMed ID: 2560175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]